Literature DB >> 1289742

Discrepancy of xenon concentrations between end-tidal and blood collection methods in xenon-enhanced computed tomographic measurements of cerebral blood flow.

M Shimoda1, S Oda, O Sato, F Kawamata, M Yamamoto.   

Abstract

Using xenon-enhanced computed tomography for the study of cerebral blood flow, simultaneous measurements of end-tidal and arterial blood xenon concentrations using the blood collection method were performed to investigate the validity of substituting the end-tidal for the arterial blood xenon concentration. Simultaneous measurement by both methods was performed 68 times in 27 patients. There was no statistical correlation between the arterial blood accumulation rate constant obtained by arterial blood and end-tidal samples, nor between the arterial blood saturation value obtained by the two methods, even when correction was made for age. In brain tissue, all parameters calculated using the end-tidal concentration were lower than those using arterial blood. We therefore suggest that cerebral blood flow values calculated using end-tidal xenon concentration are useful only for qualitative cerebral blood flow mapping, and not applicable to absolute values of cerebral blood flow.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289742     DOI: 10.1007/bf00588282

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  17 in total

1.  The anesthetic properties of xenon in animals and human beings, with additional observations on krypton.

Authors:  S C CULLEN; E G GROSS
Journal:  Science       Date:  1951-05-18       Impact factor: 47.728

2.  Early detection of endotracheal tube accidents by monitoring carbon dioxide concentration in respiratory gas.

Authors:  I P Murray; J H Modell
Journal:  Anesthesiology       Date:  1983-10       Impact factor: 7.892

Review 3.  Progress in cerebrovascular disease: local cerebral blood flow by xenon enhanced CT.

Authors:  D Gur; S K Wolfson; H Yonas; W F Good; L Shabason; R E Latchaw; D M Miller; E E Cook
Journal:  Stroke       Date:  1982 Nov-Dec       Impact factor: 7.914

4.  Computed tomographic measurement of the xenon brain-blood partition coefficient and implications for regional cerebral blood flow: a preliminary report.

Authors:  F Kelcz; S K Hilal; P Hartwell; P M Joseph
Journal:  Radiology       Date:  1978-05       Impact factor: 11.105

5.  Comparison of arterial-end-tidal PCO2 difference and dead space/tidal volume ratio in respiratory failure.

Authors:  M K Yamanaka; D Y Sue
Journal:  Chest       Date:  1987-11       Impact factor: 9.410

6.  Clinical experience with the use of xenon-enhanced CT blood flow mapping in cerebral vascular disease.

Authors:  H Yonas; S K Wolfson; D Gur; R E Latchaw; W F Good; R Leanza; D L Jackson; P J Jannetta; O M Reinmuth
Journal:  Stroke       Date:  1984 May-Jun       Impact factor: 7.914

7.  Mapping cerebral blood flow by xenon-enhanced computed tomography: clinical experience.

Authors:  H Yonas; W F Good; D Gur; S K Wolfson; R E Latchaw; B C Good; R Leanza; S L Miller
Journal:  Radiology       Date:  1984-08       Impact factor: 11.105

8.  Computed tomographic measurement of local cerebral blood flow by xenon enhancement.

Authors:  H Segawa; S Wakai; A Tamura; N Yoshimasu; O Nakamura; M Ohta
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

Review 9.  Noninvasive carbon dioxide monitoring.

Authors:  M C Stock
Journal:  Crit Care Clin       Date:  1988-07       Impact factor: 3.598

10.  Local cerebral blood flow measured by CT after stable xenon inhalation.

Authors:  J S Meyer; L A Hayman; M Yamamoto; F Sakai; S Nakajima
Journal:  AJR Am J Roentgenol       Date:  1980-08       Impact factor: 3.959

View more
  1 in total

1.  Change in regional cerebral blood flow following glycerol administration predicts. Clinical result from shunting in normal pressure hydrocephalus.

Authors:  M Shimoda; S Oda; M Shibata; A Masuko; O Sato
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.